In the face of changing dynamics for China’s tech giants, Meituan has demonstrated a commitment to strategic expansion into adjacent sectors.
Tokens related to AI all rose after Nvidia’s report, and are likely to continue reaping from institutional interest in artificial intelligence.
All eyes are on the Fed’s Jackson Hole meeting ahead this week as Fed Chair Jerome Powell is likely to announce interest rate hikes.
Driven by the high demand for AI products, Nvidia reported a significant increase in revenue and expects exponential growth ahead.
Amid the market realities, the marketing department at Nike noted that the low patronage of Foot Locker could be weighing on the sneaker giant’s shares.
Peloton sales and subscriber growth fell in Q4 2023 as expected, due to a traditional Q4 slowdown and a recall that affected 2 million bikes.
AMC announced in August that it plans to issue 517 million shares of preferred stock, under the ticker symbol APE to raise more funds and counter its debts.
The CEO of Baidu disclosed that the company saw accelerated revenue and profit growth in the Q2 of 2023 due to the good performance of the online marketing business and operating leverage.
As wage expectations surge to unprecedented heights, economists and policymakers keep a vigilant eye on the broader implications for inflation and monetary policy.
Meanwhile, investors are closely eyeing the natural gas market, where prices experienced a significant surge on Monday.
Although unknown, many believe the Bitcoin wallet may belong to a major crypto exchange moving money around, or asset manager Blackrock Inc.
In response to the initial rejection, Microsoft has introduced a new proposal that both companies have mutually accepted. The terms of this agreement have been adjusted to align with the stipulations of the UK Competition and Markets Authority.
The higher mortgage rates serve to make the supply situation worse as homeowners are unwilling to list their properties as most of them have rates around or below 3%.
Covid vaccine stocks, including Moderna, BioNTech, and Novavax have all closed higher as new vaccinations and treatments roll out.
Arm was acquired by SoftBank in 2016 for $32 billion and expects to return to public trading to compete with other chip designers and manufacturers.